• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克柔念珠菌对唑类抗真菌药物敏感性差异的起源。

Origin of differences in susceptibility of Candida krusei to azole antifungal agents.

作者信息

Marichal P, Gorrens J, Coene M C, Le Jeune L, Vanden Bossche H

机构信息

Division of Medicinal Chemistry and Pharmacology, Janssen Research Foundation, Beerse, Belgium.

出版信息

Mycoses. 1995 Mar-Apr;38(3-4):111-7. doi: 10.1111/j.1439-0507.1995.tb00032.x.

DOI:10.1111/j.1439-0507.1995.tb00032.x
PMID:7477085
Abstract

Two Candida krusei isolates were used to compare the effects of fluconazole, ketoconazole and itraconazole on growth and ergosterol synthesis, and to measure intracellular drug contents. Fifty per cent inhibition (IC50) of growth was achieved at 0.05-0.08 microM itraconazole and 0.56-1.2 microM ketoconazole, whereas 91-->100 microM fluconazole was needed to reach the IC50 value. Similar differences in sensitivity to these azole antifungal agents were seen when their effects on ergosterol synthesis from [14C]acetate were measured after 4 h and 24 h of growth. However, when the effects of the azoles on ergosterol synthesis from [14C]mevalonate by subcellular fractions were measured, fluconazole was only 2.3-6.1 times less active than itraconazole, and the IC50 values for ketoconazole were almost similar to those obtained with itraconazole. These results indicate that differences in susceptibility to itraconazole and ketoconazole are unrelated to differences in affinity for the C. krusei cytochrome P450. The much lower growth-inhibitory effects of fluconazole can also be explained partly only by a lower affinity for the P450-dependent 14 alpha-demethylase. The differences in sensitivity of both C. krusei isolates appeared to arise from differences in the intracellular itraconazole, ketoconazole and fluconazole contents. Depending on the experimental conditions, these isolates accumulated 6-41 times more itraconazole than ketoconazole and the intracellular ketoconazole content was 3.0-19.0 times higher than that of fluconazole.

摘要

使用两株克鲁斯假丝酵母菌分离株比较氟康唑、酮康唑和伊曲康唑对生长及麦角甾醇合成的影响,并测定细胞内药物含量。伊曲康唑浓度为0.05 - 0.08微摩尔/升、酮康唑浓度为0.56 - 1.2微摩尔/升时可实现50% 的生长抑制(IC50),而达到IC50值则需要91→100微摩尔/升的氟康唑。在生长4小时和24小时后测量这些唑类抗真菌药对[14C]乙酸盐合成麦角甾醇的影响时,观察到对这些唑类抗真菌药的敏感性存在类似差异。然而,当测量唑类对亚细胞组分由[14C]甲羟戊酸合成麦角甾醇的影响时,氟康唑的活性仅比伊曲康唑低2.3 - 6.1倍,酮康唑的IC50值与伊曲康唑几乎相似。这些结果表明,对伊曲康唑和酮康唑敏感性的差异与对克鲁斯假丝酵母菌细胞色素P450亲和力的差异无关。氟康唑较低的生长抑制作用部分也只能通过对P450依赖性14α-脱甲基酶较低的亲和力来解释。两株克鲁斯假丝酵母菌分离株敏感性的差异似乎源于细胞内伊曲康唑、酮康唑和氟康唑含量的差异。根据实验条件,这些分离株积累的伊曲康唑比酮康唑多6 - 41倍,细胞内酮康唑含量比氟康唑高3.0 - 19.0倍。

相似文献

1
Origin of differences in susceptibility of Candida krusei to azole antifungal agents.克柔念珠菌对唑类抗真菌药物敏感性差异的起源。
Mycoses. 1995 Mar-Apr;38(3-4):111-7. doi: 10.1111/j.1439-0507.1995.tb00032.x.
2
Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.克柔念珠菌细胞色素P450与唑类抗真菌药物的抑制作用及相互作用
J Med Vet Mycol. 1997 Jan-Feb;35(1):19-25.
3
Characterization of an azole-resistant Candida glabrata isolate.一株耐唑类光滑念珠菌分离株的鉴定
Antimicrob Agents Chemother. 1992 Dec;36(12):2602-10. doi: 10.1128/AAC.36.12.2602.
4
[Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].来自患有复发性念珠菌性口腔炎的HIV感染患者的氟康唑耐药念珠菌属:对伊曲康唑和酮康唑的交叉耐药性
Mycoses. 1997;40 Suppl 1:56-63. doi: 10.1111/j.1439-0507.1997.tb00543.x.
5
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.245株酵母分离株对两性霉素B、5-氟胞嘧啶、酮康唑、氟康唑和伊曲康唑的体外药敏试验
Chemotherapy. 1992;38(5):335-9. doi: 10.1159/000239023.
6
In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.D0870与其他唑类药物相比对氟康唑耐药念珠菌属的体外活性
Antimicrob Agents Chemother. 1995 Apr;39(4):868-71. doi: 10.1128/AAC.39.4.868.
7
Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.伏立康唑对氟康唑敏感和耐药念珠菌分离株的作用:与伊曲康唑和酮康唑相比的体外疗效
J Antimicrob Chemother. 1998 Aug;42(2):253-6. doi: 10.1093/jac/42.2.253.
8
Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates.肉汤微量稀释法最低抑菌浓度(MIC)终点测定的视觉法与分光光度法比较以及氟康唑和伊曲康唑对拖尾和非拖尾念珠菌分离株体外药敏试验中一种甾醇定量方法的评估
Antimicrob Agents Chemother. 2002 Aug;46(8):2477-81. doi: 10.1128/AAC.46.8.2477-2481.2002.
9
Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.氟康唑、伊曲康唑和酮康唑的体外活性:一项对比研究
J Chemother. 1991 Jun;3(3):139-42. doi: 10.1080/1120009x.1991.11739080.
10
Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.来自患有口腔念珠菌病的HIV阳性患者的念珠菌分离株中具有临床意义的唑类交叉耐药性。
AIDS. 1997 Dec;11(15):1839-44. doi: 10.1097/00002030-199715000-00008.

引用本文的文献

1
Repurposing the phenylthiazole scaffold with 1,3,4-oxadiazole for selective, potent and well-tolerated antifungal activity.将含有1,3,4-恶二唑的苯基噻唑支架用于选择性、强效且耐受性良好的抗真菌活性研究。
RSC Adv. 2025 Mar 27;15(12):9305-9319. doi: 10.1039/d5ra00499c. eCollection 2025 Mar 21.
2
Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin.Q-格里菲辛的新型抗真菌活性,一种广谱抗病毒凝集素。
Microbiol Spectr. 2021 Oct 31;9(2):e0095721. doi: 10.1128/Spectrum.00957-21. Epub 2021 Sep 8.
3
Fluconazole resistance in species: a current perspective.
物种中的氟康唑耐药性:当前观点。
Infect Drug Resist. 2017 Jul 31;10:237-245. doi: 10.2147/IDR.S118892. eCollection 2017.
4
Azole Antifungal Resistance in and Emerging Non- Species.非白色念珠菌中的唑类抗真菌药物耐药性及新出现的非白色念珠菌。
Front Microbiol. 2017 Jan 12;7:2173. doi: 10.3389/fmicb.2016.02173. eCollection 2016.
5
Identification and Sequencing of Candida krusei Aconitate Hydratase Gene Using Rapid Amplification of cDNA Ends Method and Phylogenetic Analysis.利用cDNA末端快速扩增法鉴定和测序克鲁斯假丝酵母乌头酸水合酶基因及系统发育分析
Jundishapur J Microbiol. 2015 Nov 21;8(11):e25218. doi: 10.5812/jjm.25218. eCollection 2015 Nov.
6
Upregulation of the ERG11 gene in Candida krusei by azoles.唑类药物对克柔念珠菌 ERG11 基因的上调作用。
Daru. 2010;18(4):276-80.
7
Efflux-mediated antifungal drug resistance.外排介导的抗真菌药物耐药性。
Clin Microbiol Rev. 2009 Apr;22(2):291-321, Table of Contents. doi: 10.1128/CMR.00051-08.
8
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.Abc1p是一种多药外排转运蛋白,它使克鲁斯念珠菌对唑类药物的固有耐药性占优势。
Antimicrob Agents Chemother. 2009 Feb;53(2):354-69. doi: 10.1128/AAC.01095-08. Epub 2008 Nov 17.
9
Species distribution and susceptibility to azoles of vaginal yeasts isolated prostitutes.从妓女中分离出的阴道酵母菌的种类分布及对唑类药物的敏感性
Infect Dis Obstet Gynecol. 2007;2007:82412. doi: 10.1155/2007/82412.
10
Strong antifungal activity of SS750, a new triazole derivative, is based on its selective binding affinity to cytochrome P450 of fungi.新型三唑衍生物SS750具有强大的抗真菌活性,这基于其对真菌细胞色素P450的选择性结合亲和力。
Antimicrob Agents Chemother. 2002 Feb;46(2):308-14. doi: 10.1128/AAC.46.2.308-314.2002.